Universal genotyping in Tuberculosis Control Program, New York City, 2001-2003

Emerging Infectious Diseases

Volumn 12, Issue 5, 2006, Pages 719-724

  Clark, Carla M ^a   Driver, Cynthia R ^a   Munsiff, Sonal S ^a,b   Driscoll, Jeffrey R ^c   Kreiswirth, Barry N ^d   Zhao, Benyang ^e   Ebrahimzadeh, Adeleh ^e   Salfinger, Max ^c   Piatek, Amy S ^a   Abdelwahab, Jalaa' ^b   Agerton, Tracy ^f   Beatrice, Sara ^f   Costarella, Roseann ^f   Fernandez, Rafael ^f   Gallagher, Dolores ^f   Granville, Karen ^f   Kurepina, Natalia ^f   Laraque, Fabienne ^f   Li, Jiehui ^f   Macaraig, Michelle ^f   Mathema, Barun ^f   Palumbo, Lucille ^f   Parsons, Linda ^f   Ravikovitch, Alex ^f   Taber, Harry ^f   Wiseman, Rachel ^f   Zickas, Genet ^f   more..

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WADSWORTH CENTER   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e Public Health Laboratory   (United States)

^f Box 72B ^*

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM CULTURE; DATA BASE; FALSE POSITIVE RESULT; GENE CLUSTER; GENOTYPE; HEALTH PROGRAM; HUMAN; LABORATORY TEST; MYCOBACTERIUM TUBERCULOSIS; QUALITY CONTROL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; TUBERCULOSIS CONTROL; UNITED STATES;

EID: 33646549920     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1205.050446     Document Type: Review

References (31)

1. Valway SE, Richards SB, Kovacovich J, Greifinger RB, Crawford JT, Dooley SW. Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol. 1994;140:113-22.
2. Coronado VG, Beck-Sague CM, Hutton MD, Davis BJ, Nicholas P, Villareal C, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168:1052-5.
3. Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, et al. A multi-institutional outbreak of highly drug resistant tuberculosis. JAMA. 1996;276:1229-35.
4. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330:1710-6.
5. Nivin B, Nicholas P, Gayer M, Frieden TR, Fujiwara PI. A continuing outbreak of multidrug-resistant tuberculosis, with transmission in a hospital nursery. Clin Infect Dis. 1998;26:303-7.
6. Munsiff SS, Bassoff T, Nivin B, Li J, Sharma A, Bifani P, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis. 2002;8:1230-8.
7. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med. 1995;333:229-33.
8. Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley SM. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tuber Lung Dis. 1996;77:407-13.
9. Castro KG, Jaffe HW. Rationale and methods for the National Tuberculosis Genotyping and Surveillance Network. Emerg Infect Dis. 2002;8:1188-91.
10. Crawford JT, Braden CR, Schable BA, Onorato IM. National Tuberculosis Genotyping and Surveillance Network: design and methods. Emerg Infect Dis. 2002;8:1192-6.
11. Cowan LS, Crawford JT. Genotype analysis of Mycobacterium tuberculosis isolates from a sentinel surveillance population. Emerg Infect Dis. 2002;8:1294-302.
12. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco - a population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703-9.
13. Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med. 1999;130:971-8.
14. van Soolingen D, Borgdorff MW, de Haas PEW, Sebek MMGG, Veen J, Dessens M, et al. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis. 1999;180:726-36.
15. van Deutekom H, Gerritsen JJJ, van Soolingen D, van Ameijden EJC, van Embden JDA, Coutinho RA. Molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis. 1997;25:1071-7.
16. Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PE, Veen J, van Embden JD. Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting. Am J Epidemiol. 1998;147:187-95.
17. Fujiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN, et al. A continuing survey of drug-resistant tuberculosis, New York, April 1994. Arch Intern Med. 1997;157:531-6.
18. New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control Annual Report. New York: The Department; 2001.
19. New York City Public Health Code, Article 13, Section 13.05, 2000.
20. Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PWM, Martin C, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999;37:2607-18.
21. Soini H, Pan X, Teeter L, Musser JM, Graviss EA. Transmission dynamics and molecular characterization of Mycobacterium tuberculosis isolates with low copy number of IS6110. J Clin Microbiol. 2001;39:217-21.
22. Goyal M, Saunders NA, van Embden JDA, Young DB, Shaw RJ. Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism. J Clin Microbiol. 1997;35:647-51.
23. Bauer J, Andersen AB, Kremer K, Miörner H. Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol. 1999;37:2602-6.
24. Rasolofo-Razanamparany V, Ramarokoto H, Aurëgan G, Gicquel B, Chanteau S. A combination of two genetic markers is sufficient for restriction fragment length polymorphism typing of Mycobacterium tuberculosis complex in areas with a high incidence of tuberculosis. J Clin Microbiol. 2001;39:1530-5.
25. Kamerbeek J, Schouls L, Kolk A, van Agterveld D, van Soolingen D, Kuijpers S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907-14.
26. Driscoll JR, Bifani PJ, Mathema B, McGarry MA, Zickas GM, Kreiswirth BN, et al. Spoligologos: a bioinformatic approach to displaying and analyzing Mycobacterium tuberculosis data. Emerg Infect Dis. 2002;8:1306-9.
27. Dale JW, Brittain D, Cataldi AA, Cousins D, Crawford JT, Driscoll J, et al. Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standard nomenclature. Int J Tuberc Lung Dis. 2001;5:216-9.
28. Kreiswirth BN, Moss AR. Genotyping multidrug-resistant M. tuberculosis in New York City. In: Rom WN, Garay SM, editors. Tuberculosis. Boston: Little, Brown, and Company, Inc; 1996. p. 199-209.
29. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-9.
30. Ellis BA, Crawford JT, Braden CR, McNabb SJN, Moore M, Kammerer S, et al. Molecular epidemiology of tuberculosis in a sentinel surveillance population. Emerg Infect Dis. 2002;8:1197-209.
31. National TB Controllers Association/Centers for Disease Control Advisory Group on Tuberculosis Genotyping. Guide to the application of genotyping to tuberculosis prevention and control. Atlanta: US Department of Health and Human Services; 2004.